Dynamic In Vitro Models of the Human Gastrointestinal Tract As Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota

Overview

Journal Microorganisms

Specialty Microbiology

Date 2016 Sep 30

PMID 27682114

Citations 33

Authors

Charlotte Cordonnier

Jonathan Thevenot

Lucie Etienne-Mesmin

Sylvain Denis

Monique Alric

Valerie Livrelli

Stephanie Blanquet-Diot

Affiliations

Soon will be listed here.

Abstract

The beneficial effects of probiotics are conditioned by their survival during passage through the human gastrointestinal tract and their ability to favorably influence gut microbiota. The main objective of this study was to use dynamic in vitro models of the human digestive tract to investigate the effect of fasted or fed state on the survival kinetics of the new probiotic Saccharomyces cerevisiae strain CNCM I-3856 and to assess its influence on intestinal microbiota composition and activity. The probiotic yeast showed a high survival rate in the upper gastrointestinal tract whatever the route of admistration, i.e., within a glass of water or a Western-type meal. S. cerevisiae CNCM I-3856 was more sensitive to colonic conditions, as the strain was not able to colonize within the bioreactor despite a twice daily administration. The main bacterial populations of the gut microbiota, as well as the production of short chain fatty acids were not influenced by the probiotic treatment. However, the effect of the probiotic on the gut microbiota was found to be individual dependent. This study shows that dynamic in vitro models can be advantageously used to provide useful insight into the behavior of probiotic strains in the human digestive environment.

Citing Articles

In Vitro Cholesterol Uptake by the Microflora of Selected Kefir Starter Cultures.

Ziarno M, Zareba D, Scibisz I, Kozlowska M Life (Basel). 2024; 14(11).

PMID: 39598262 PMC: 11595744. DOI: 10.3390/life14111464.

A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden.

Rebeck O, Wallace M, Prusa J, Ning J, Evbuomwan E, Rengarajan S Cell Chem Biol. 2024; 32(1):98-110.e7.

PMID: 39571582 PMC: 11741927. DOI: 10.1016/j.chembiol.2024.10.013.

Impact of Western Diet on Enterohemorrhagic Colonization in the Human Mucosal Artificial Colon as Mediated by Gut Microbiota.

OSullivan D, Arora T, Durif C, Uriot O, Brun M, Riu M Nutrients. 2024; 16(13).

PMID: 38999794 PMC: 11243482. DOI: 10.3390/nu16132046.

Meta-analysis of the Microbial Diversity Cultured in Bioreactors Simulating the Gut Microbiome.

Mendez D, Egan S, Wist J, Holmes E, Sanabria J Microb Ecol. 2024; 87(1):57.

PMID: 38587527 PMC: 11001690. DOI: 10.1007/s00248-024-02369-0.

Characterization of the Effects of a Novel Probiotic on Colonization of a Piglet-Derived Intestinal Microbiota Using Improved Bioreactor.

Grandmont A, Rhouma M, Letourneau-Montminy M, Theriault W, Mainville I, Arcand Y Animals (Basel). 2024; 14(5).

PMID: 38473172 PMC: 10930937. DOI: 10.3390/ani14050787.

References

Koziolek M, Grimm M, Becker D, Iordanov V, Zou H, Shimizu J . Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System. J Pharm Sci. 2014; 104(9):2855-63. DOI: 10.1002/jps.24274. View

Swidsinski A, Loening-Baucke V, Kirsch S, Doerffel Y . [Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii]. Gastroenterol Clin Biol. 2010; 34 Suppl 1:S79-92. DOI: 10.1016/S0399-8320(10)70025-7. View

Vertzoni M, Archontaki H, Reppas C . Determination of intralumenal individual bile acids by HPLC with charged aerosol detection. J Lipid Res. 2008; 49(12):2690-5. DOI: 10.1194/jlr.D800039-JLR200. View

Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B . Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11(8):506-14. DOI: 10.1038/nrgastro.2014.66. View

Yu Z, Morrison M . Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques. 2004; 36(5):808-12. DOI: 10.2144/04365ST04. View

Blanquet-Diot S, Denis S, Chalancon S, Chaira F, Cardot J, Alric M . Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans. Pharm Res. 2011; 29(6):1444-53. DOI: 10.1007/s11095-011-0620-5. View

Pecquet S, Guillaumin D, Tancrede C, Andremont A . Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice. Appl Environ Microbiol. 1991; 57(10):3049-51. PMC: 183921. DOI: 10.1128/aem.57.10.3049-3051.1991. View

Murray R, Eddy D, Bartoli W, PAUL G . Gastric emptying of water and isocaloric carbohydrate solutions consumed at rest. Med Sci Sports Exerc. 1994; 26(6):725-32. DOI: 10.1249/00005768-199406000-00012. View

Huijsdens X, Linskens R, Mak M, Meuwissen S, Vandenbroucke-Grauls C, Savelkoul P . Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol. 2002; 40(12):4423-7. PMC: 154607. DOI: 10.1128/JCM.40.12.4423-4427.2002. View

10.

Im E, Pothoulakis C . [Recent advances in Saccharomyces boulardii research]. Gastroenterol Clin Biol. 2010; 34 Suppl 1:S62-70. DOI: 10.1016/S0399-8320(10)70023-3. View

11.

Furet J, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S . Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol. 2009; 68(3):351-62. DOI: 10.1111/j.1574-6941.2009.00671.x. View

12.

Martinez-Medina M, Denizot J, Dreux N, Robin F, Billard E, Bonnet R . Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut. 2013; 63(1):116-24. DOI: 10.1136/gutjnl-2012-304119. View

13.

Sivignon A, de Vallee A, Barnich N, Denizot J, Darcha C, Pignede G . Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease. Inflamm Bowel Dis. 2015; 21(2):276-86. DOI: 10.1097/MIB.0000000000000280. View

14.

Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, Huys G . Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol. 2006; 72(9):5990-7. PMC: 1563651. DOI: 10.1128/AEM.00233-06. View

15.

Cheow W, Kiew T, Hadinoto K . Controlled release of Lactobacillus rhamnosus biofilm probiotics from alginate-locust bean gum microcapsules. Carbohydr Polym. 2014; 103:587-95. DOI: 10.1016/j.carbpol.2014.01.036. View

16.

Klein S, Elmer G, McFarland L, Surawicz C, Levy R . Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharm Res. 1993; 10(11):1615-9. DOI: 10.1023/a:1018924820333. View

17.

Elashoff J, Reedy T, Meyer J . Analysis of gastric emptying data. Gastroenterology. 1982; 83(6):1306-12. View

18.

Bolnick D, Snowberg L, Hirsch P, Lauber C, Org E, Parks B . Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun. 2014; 5:4500. PMC: 4279269. DOI: 10.1038/ncomms5500. View

19.

MacFarlane , Gibson . Validation of a Three-Stage Compound Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and Metabolism of Bacteria in the Human Colon. Microb Ecol. 1998; 35(2):180-7. DOI: 10.1007/s002489900072. View

20.

Hatoum R, Labrie S, Fliss I . Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications. Front Microbiol. 2012; 3:421. PMC: 3525881. DOI: 10.3389/fmicb.2012.00421. View